419 related articles for article (PubMed ID: 33512315)
61. Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman.
de Boer M; van der Sluis WB; de Boer JP; Overbeek LIH; van Leeuwen FE; Rakhorst HA; van der Hulst RRWJ; Hijmering NJ; Bouman MB; de Jong D
Aesthet Surg J; 2017 Sep; 37(8):NP83-NP87. PubMed ID: 29036941
[TBL] [Abstract][Full Text] [Related]
62. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk.
Loch-Wilkinson A; Beath KJ; Knight RJW; Wessels WLF; Magnusson M; Papadopoulos T; Connell T; Lofts J; Locke M; Hopper I; Cooter R; Vickery K; Joshi PA; Prince HM; Deva AK
Plast Reconstr Surg; 2017 Oct; 140(4):645-654. PubMed ID: 28481803
[TBL] [Abstract][Full Text] [Related]
63. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Why Must We Learn About It?
de Oliveira Sermoud LMC; Romano S; Chveid M; da Silva Amorim GL
J Glob Oncol; 2019 Aug; 5():1-5. PubMed ID: 31454283
[TBL] [Abstract][Full Text] [Related]
64. Smooth Versus Textured Tissue Expander Breast Reconstruction: Complications and Efficacy.
McLaughlin C; Hughes AJ; Parham CS; Fritsche M; Potochny JD; Kunselman A; Ravnic DJ
Ann Plast Surg; 2022 May; 88(3 Suppl 3):S288-S292. PubMed ID: 35513333
[TBL] [Abstract][Full Text] [Related]
65. Public Interest in Textured Breast Implants Recall: A Google Trends Analysis.
Dayani F; Tijerina JD; Morrison SD; Nazerali RS
Aesthetic Plast Surg; 2020 Oct; 44(5):1489-1497. PubMed ID: 32356152
[TBL] [Abstract][Full Text] [Related]
66. BIA-ALCL Epidemiological Findings From a Retrospective Study of 248 Cases Extracted From Relevant Case Reports and Series: A Systematic Review.
Santanelli Di Pompeo F; Panagiotakos D; Firmani G; Sorotos M
Aesthet Surg J; 2023 Apr; 43(5):545-555. PubMed ID: 36441968
[TBL] [Abstract][Full Text] [Related]
67. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
[TBL] [Abstract][Full Text] [Related]
68. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma.
Los-de Vries GT; de Boer M; van Dijk E; Stathi P; Hijmering NJ; Roemer MGM; Mendeville M; Miedema DM; de Boer JP; Rakhorst HA; van Leeuwen FE; van der Hulst RRWJ; Ylstra B; de Jong D
Blood; 2020 Dec; 136(25):2927-2932. PubMed ID: 33331925
[TBL] [Abstract][Full Text] [Related]
69. A Different Perspective on Breast Implant Surface Texturization and Anaplastic Large Cell Lymphoma (ALCL).
Brown T; Harvie F; Stewart S
Aesthet Surg J; 2019 Jan; 39(1):56-63. PubMed ID: 29659699
[TBL] [Abstract][Full Text] [Related]
70. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
[TBL] [Abstract][Full Text] [Related]
71. Surgical Management and Long-Term Outcomes of BIA-ALCL: A Multidisciplinary Approach.
Vorstenbosch J; Ghione P; Plitas G; Horwitz S; Kim M; Cordeiro P; Nelson J; McCarthy C
Ann Surg Oncol; 2024 Mar; 31(3):2032-2040. PubMed ID: 38102324
[TBL] [Abstract][Full Text] [Related]
72. Incidental Bystander or Essential Culprit: A Systematic Review of Bacterial Significance in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Foppiani JA; Raska O; Taritsa I; Hernandez Alvarez A; Lee D; Escobar-Domingo MJ; Berger J; Klener P; Schuster KA; Abdo D; Clemens MW; Lin SJ
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203524
[TBL] [Abstract][Full Text] [Related]
73. Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the Breast.
de Boer M; van Leeuwen FE; Hauptmann M; Overbeek LIH; de Boer JP; Hijmering NJ; Sernee A; Klazen CAH; Lobbes MBI; van der Hulst RRWJ; Rakhorst HA; de Jong D
JAMA Oncol; 2018 Mar; 4(3):335-341. PubMed ID: 29302687
[TBL] [Abstract][Full Text] [Related]
74. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities.
DeCoster RC; Lynch EB; Bonaroti AR; Miranda RN; Hunt KK; Clemens MW
Clin Plast Surg; 2021 Jan; 48(1):33-43. PubMed ID: 33220903
[TBL] [Abstract][Full Text] [Related]
75. Is Breast Implant-Associated Anaplastic Large Cell Lymphoma Better Classified as a Lymphoproliferative Disorder and How Surgeons Reduce Risk?
Lukavsky RJ; Couto RA; Adams WP
Clin Plast Surg; 2021 Jan; 48(1):71-77. PubMed ID: 33220906
[TBL] [Abstract][Full Text] [Related]
76. A National Survey to Assess the Population's Perception of Breast Implant-Associated Anaplastic Large Cell Lymphoma and Breast Implant Illness.
Azzi AJ; Almadani Y; Davison P
Plast Reconstr Surg; 2021 Apr; 147(4):795-803. PubMed ID: 33776025
[TBL] [Abstract][Full Text] [Related]
77. Financial Toxicity in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Tesfaye EA; O'Neill RC; McGregor T; Clemens MW
Ann Plast Surg; 2024 Jan; 92(1):34-40. PubMed ID: 37994417
[TBL] [Abstract][Full Text] [Related]
78. [Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)].
Hedén P; Stark B
Lakartidningen; 2018 Jun; 115():. PubMed ID: 29917175
[TBL] [Abstract][Full Text] [Related]
79. U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Doren EL; Miranda RN; Selber JC; Garvey PB; Liu J; Medeiros LJ; Butler CE; Clemens MW
Plast Reconstr Surg; 2017 May; 139(5):1042-1050. PubMed ID: 28157769
[TBL] [Abstract][Full Text] [Related]
80. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
